Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

ABSTRACT: A Phase I/II study of autologous T cells engineered using the Sleeping Beauty transposon/transposase system to express TCR(s) reactive against neoantigens in subjects with relapsed/refractory solid tumors

DISEASE(S): Endometrial Cancer,Colorectal Cancer,Endometrial Neoplasms,Pancreatic Cancer,Lung Neoplasms,Ovarian Cancer,Squamous Cell Lung Cancer,Gynecologic Cancer,Ovarian Carcinoma,Adenosquamous Cell Lung Cancer,Non-small Cell Lung Cancer,Ovarian Neoplasms,Adenocarcinoma Of Lung,Cholangiocarcinoma,Ovary Neoplasm

PROVIDER: 2401213 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR